Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00208949 Comparator | Sep 2002 → May 2010 | hematologic disorder | Emory University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00208949 ↗ |
| Route | Subcutaneous | “G-CSF, solution given subcutaneously twice per day, total dosage varies by weight.” NCT00208949 ↗ |